Papers
1
Total Citations
26
H-Index
1
About
Dr. Yibo Fu is a leading surgical oncologist whose research centers on advancing minimally invasive techniques for complex pancreatic surgeries. His most impactful work involves rigorous meta-analyses comparing robotic versus open pancreaticoduodenectomy—one of the most challenging abdominal procedures. In his landmark 2022 study, which has garnered 26 citations, Dr. Fu synthesized evidence from multiple cohort studies to evaluate perioperative outcomes for all patients and specifically those with pancreatic cancer. His analysis demonstrated that robotic pancreaticoduodenectomy (RPD) can achieve comparable or superior results to open surgery, including reduced blood loss and shorter hospital stays, without compromising oncologic outcomes such as R0 resection rates or lymph node harvest. This work has provided crucial evidence supporting the adoption of robotic approaches in high-volume centers. Dr. Fu’s contributions are helping to shape modern pancreatic cancer surgery by balancing the benefits of minimally invasive techniques with the need for safe, effective oncologic resection. His research continues to influence clinical guidelines and inspire further prospective trials in this rapidly evolving field.
Research Focus
Key Achievements
Top Papers
- 1